Vanta Bioscience

quarterly
yearly
ParticularsDec '22
Revenue2.83
Expenses7.16
EBITDA-0.54
EBIT0.01
Profit Before Tax-2.47
Net Profit-2.56
Financial Ratios
Operating Profit Margin-19.15%
Net Profit Margin-90.78%
Earning Per Share (Diluted)-4.06
Dividends Per Share0.00